Metraipolis › archive › dc_bfc9db1d8d0a
Pharmacogenomics in drug therapy: global regulatory guidelines for managing high-risk drug reactions — Europe PMC PMID:40993225
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40993225
- DOI
- 10.1038/s41431-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T19:20:11.285Z
- SHA-256 of the archived text
dfdc4bbe419272c194f110a672e24bd9a7fd98608388caa0e52f942330cccd4b- Stable URL of this page
https://metraipolis.com/documento/dc_bfc9db1d8d0a
How to cite
Pharmacogenomics in drug therapy: global regulatory guidelines for managing high-risk drug reactions — Europe PMC PMID:40993225 — Europe PMC (en), https://europepmc.org/article/MED/40993225 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfc9db1d8d0a (Metraipolis archive dc_bfc9db1d8d0a, sha256 dfdc4bbe419272c194f110a672e24bd9a7fd98608388caa0e52f942330cccd4b)
BibTeX
@misc{dcbfc9db1d8d0a,
title = {Pharmacogenomics in drug therapy: global regulatory guidelines for managing high-risk drug reactions — Europe PMC PMID:40993225},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40993225},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfc9db1d8d0a; sha256 dfdc4bbe419272c194f110a672e24bd9a7fd98608388caa0e52f942330cccd4b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40993225. Agents can read the archived copy with the MCP tool read_document.